Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that the Centers for Medicare and Medicaid Services (CMS) has issued guidance clarifying that Medicare Part D Plan Sponsors can provide coverage for products such as the Omnipod System under the Medicare Part D (prescription drug) program.